LightHearted AI

London, United Kingdom · Founded 2023 · Privately Held (backing)

Developer of a medical device intended to prevent heart-related deaths. LightHearted AI is based in London, United Kingdom and was founded in 2023. Its last reported valuation was $6.4 million in Aug 2024. It has raised $3.8 million.

Last reported valuation
$6.4M
Oct 2026
Priced at
—
Total raised
$3.8M
Last round
—

LightHearted AI key facts

as of Oct 2026
  • Developer of a medical device intended to prevent heart-related deaths.
  • LightHearted AI is valued at approximately $6.4M as of Oct 2026 (last reported valuation).
  • It has raised $3.8M; the latest was Accelerator/Incubator in Jun 2025.
  • Notable investors include SOSV, MedTech Innovator, Entrepreneurs First, HAX, SyndicateRoom — 12 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$6.4M

LightHearted AI's last reported valuation, Aug 2024. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of LightHearted AI with a free account
  • ·The complete investor list: 12 names
  • ·Watch LightHearted AI: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

LightHearted AI funding rounds

No rounds on record

No funding rounds for LightHearted AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

LightHearted AI valuation

LightHearted AI's last reported valuation was $6.4 million in Aug 2024. No priced round, secondary trade or fund mark has surfaced since.

LightHearted AI investors

12 investors are on record for LightHearted AI, including SOSV, MedTech Innovator, Entrepreneurs First and HAX. By type, the record holds 6 venture capital firms, 1 family office and 1 angel investor.

About LightHearted AI

Developer of a medical device intended to prevent heart-related deaths. The company's medical device helps in the detection of heart conditions, offering faster, accurate, and affordable support compared to existing technologies, enabling healthcare professionals to improve treatment procedures.

Sector
Healthcare
HQ
London, United Kingdom
Founded
2023
Employees
15
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.